Trends in Thumb Carpometacarpal Arthroplasty: A Decade in Review
- PMID: 40879102
- PMCID: PMC12397088
- DOI: 10.1177/15589447251360266
Trends in Thumb Carpometacarpal Arthroplasty: A Decade in Review
Abstract
Background: Carpometacarpal (CMC) arthroplasty can provide symptomatic relief and improvement in function in patients with CMC osteoarthritis. The study purpose was to identify demographic, 30-day outcome, and reimbursement trends in CMC arthroplasty between 2012 and 2021.
Methods: This was a retrospective cohort study of adult patients undergoing CMC arthroplasty from January 1, 2012, to December 31, 2021, using the National Surgical Quality Improvement Program database. Patients were stratified based on year of index surgery: 2012-2015, 2016-2018, and 2019-2021. Baseline characteristics were collected and compared using the appropriate statistical test. Multivariable logistic regressions controlling for age and sex were performed to identify independent risk factors for 30-day morbidity, readmissions, and reoperations. Economic analyses assessed changes in reimbursement rates over the span of 10 years.
Results: A total of 9046 patients were included in the analysis with mean age of 62.7 ± 9.2 and women comprising 74.9% of the total population. Between 2012 and 2021, the annual volume increased from 433 to 1043. The average body mass index (BMI) and proportion of patients with congestive heart failure (CHF) increased in 2019-2021. Increasing age, BMI, smoking, and length of stay ≥ 1 day were independent risk factors for 30-day readmissions. The Medicare reimbursement fee decreased by an average of 1.15% annually, for a total of 9.90% across 10 years.
Conclusions: The volume of CMC arthroplasty has risen from 2012 to 2021. However, conditions such as obesity and CHF have become more prevalent. Despite the growing patient complexity, Medicare reimbursement fees have markedly decreased.
Keywords: CMC; arthritis; arthroplasty; diagnosis; epidemiology; osteoarthritis; outcomes; reimbursements; research & health outcomes; research and health outcomes.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures



Similar articles
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
-
Dorsal Subluxation of the First Metacarpal During Thumb Flexion is an Indicator of Carpometacarpal Osteoarthritis Progression.Clin Orthop Relat Res. 2023 Jun 1;481(6):1224-1237. doi: 10.1097/CORR.0000000000002575. Epub 2023 Mar 6. Clin Orthop Relat Res. 2023. PMID: 36877171 Free PMC article.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Elective THA for Indications Other Than Osteoarthritis Is Associated With Increased Cost and Resource Use: A Medicare Database Study of 135,194 Claims.Clin Orthop Relat Res. 2024 Jul 1;482(7):1159-1170. doi: 10.1097/CORR.0000000000002922. Epub 2023 Nov 24. Clin Orthop Relat Res. 2024. PMID: 38011034 Free PMC article.
-
What Are the Most Clinically Effective Nonoperative Interventions for Thumb Carpometacarpal Osteoarthritis? An Up-to-date Systematic Review and Network Meta-analysis.Clin Orthop Relat Res. 2025 Apr 1;483(4):719-736. doi: 10.1097/CORR.0000000000003300. Epub 2024 Nov 19. Clin Orthop Relat Res. 2025. PMID: 39560669
References
-
- Werner BC, Bridgforth AB, Gwathmey FW, Dacus AR. Trends in thumb carpometacarpal interposition arthroplasty in the United States, 2005-2011. Am J Orthop (Belle Mead NJ). 2015;44(8):363-368. - PubMed
LinkOut - more resources
Full Text Sources